Cargando…

Evaluation of transfer media containing different concentrations of hyaluronan for human in vitro fertilization

PURPOSE: The aim of the present prospective study was to investigate the efficacy of hyaluronan (HA) using two different concentrations as embryo transfer media for in vitro fertilization embryo transfer cycles. METHODS: A total of 169 cycles undergoing fresh embryo transfer on day 2 or 3, 561 cycle...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishihara, Takuji, Morimoto, Yoshiharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715902/
https://www.ncbi.nlm.nih.gov/pubmed/29259488
http://dx.doi.org/10.1002/rmb2.12051
_version_ 1783283836291907584
author Nishihara, Takuji
Morimoto, Yoshiharu
author_facet Nishihara, Takuji
Morimoto, Yoshiharu
author_sort Nishihara, Takuji
collection PubMed
description PURPOSE: The aim of the present prospective study was to investigate the efficacy of hyaluronan (HA) using two different concentrations as embryo transfer media for in vitro fertilization embryo transfer cycles. METHODS: A total of 169 cycles undergoing fresh embryo transfer on day 2 or 3, 561 cycles undergoing frozen‐thawed embryo transfer on day 2 or 3, and 484 cycles of frozen‐thawed blastocyst transfer were included in this study. Patients were randomly divided into two groups: transferred with low (l‐HA) or high (h‐HA) concentrations of HA in transfer media. RESULTS: In the case of fresh embryo transfer cycles, no significant differences were observed in the pregnancy (l‐HA 27.2%, h‐HA 31.2%), implantation (l‐HA 22.1%, h‐HA 24.2%), or abortion (l‐HA 24.0%, h‐HA 20.8%) rates between the two groups. In the case of frozen‐thawed embryo transfer cycles, no significant differences were noted in the pregnancy (l‐HA 20.9%, h‐HA 22.9%), implantation (l‐HA 13.4%, h‐HA 15.8%), or abortion (l‐HA 17.2%, h‐HA 21.5%) rates. In the case of frozen‐thawed blastocyst transfer cycles, no significant differences were observed in the pregnancy (l‐HA 46.0%, h‐HA 41.8%), implantation (l‐HA 45.8%, h‐HA 41.3%), or abortion (l‐HA 17.6%, h‐HA 26.9%) rates. CONCLUSION: The present results showed that pregnancy, implantation, and abortion rates with transfer media containing different HA concentrations were similar.
format Online
Article
Text
id pubmed-5715902
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57159022017-12-19 Evaluation of transfer media containing different concentrations of hyaluronan for human in vitro fertilization Nishihara, Takuji Morimoto, Yoshiharu Reprod Med Biol Original Articles PURPOSE: The aim of the present prospective study was to investigate the efficacy of hyaluronan (HA) using two different concentrations as embryo transfer media for in vitro fertilization embryo transfer cycles. METHODS: A total of 169 cycles undergoing fresh embryo transfer on day 2 or 3, 561 cycles undergoing frozen‐thawed embryo transfer on day 2 or 3, and 484 cycles of frozen‐thawed blastocyst transfer were included in this study. Patients were randomly divided into two groups: transferred with low (l‐HA) or high (h‐HA) concentrations of HA in transfer media. RESULTS: In the case of fresh embryo transfer cycles, no significant differences were observed in the pregnancy (l‐HA 27.2%, h‐HA 31.2%), implantation (l‐HA 22.1%, h‐HA 24.2%), or abortion (l‐HA 24.0%, h‐HA 20.8%) rates between the two groups. In the case of frozen‐thawed embryo transfer cycles, no significant differences were noted in the pregnancy (l‐HA 20.9%, h‐HA 22.9%), implantation (l‐HA 13.4%, h‐HA 15.8%), or abortion (l‐HA 17.2%, h‐HA 21.5%) rates. In the case of frozen‐thawed blastocyst transfer cycles, no significant differences were observed in the pregnancy (l‐HA 46.0%, h‐HA 41.8%), implantation (l‐HA 45.8%, h‐HA 41.3%), or abortion (l‐HA 17.6%, h‐HA 26.9%) rates. CONCLUSION: The present results showed that pregnancy, implantation, and abortion rates with transfer media containing different HA concentrations were similar. John Wiley and Sons Inc. 2017-08-18 /pmc/articles/PMC5715902/ /pubmed/29259488 http://dx.doi.org/10.1002/rmb2.12051 Text en © 2017 The Authors. Reproductive Medicine and Biology published by John Wiley & Sons Australia, Ltd on behalf of Japan Society for Reproductive Medicine. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Nishihara, Takuji
Morimoto, Yoshiharu
Evaluation of transfer media containing different concentrations of hyaluronan for human in vitro fertilization
title Evaluation of transfer media containing different concentrations of hyaluronan for human in vitro fertilization
title_full Evaluation of transfer media containing different concentrations of hyaluronan for human in vitro fertilization
title_fullStr Evaluation of transfer media containing different concentrations of hyaluronan for human in vitro fertilization
title_full_unstemmed Evaluation of transfer media containing different concentrations of hyaluronan for human in vitro fertilization
title_short Evaluation of transfer media containing different concentrations of hyaluronan for human in vitro fertilization
title_sort evaluation of transfer media containing different concentrations of hyaluronan for human in vitro fertilization
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715902/
https://www.ncbi.nlm.nih.gov/pubmed/29259488
http://dx.doi.org/10.1002/rmb2.12051
work_keys_str_mv AT nishiharatakuji evaluationoftransfermediacontainingdifferentconcentrationsofhyaluronanforhumaninvitrofertilization
AT morimotoyoshiharu evaluationoftransfermediacontainingdifferentconcentrationsofhyaluronanforhumaninvitrofertilization